Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Atomera (NASDAQ:ATOM) executives said the company made progress across several customer engagements during its first-quarter 2026 earnings call, highlighting momentum in advanced logic, memory, RF, power devices, and gallium nitride (GaN) applications for its Mears Silicon Technology (MST). Gate-Al
Moby summary of GLOBALFOUNDRIES Inc.'s Q1 2026 earnings call
In the latest trading session, Synopsys (SNPS) closed at $497.5, marking a +1.73% move from the previous day.
Why Synopsys (SNPS) is on investors’ radar today Synopsys (SNPS) stock has been drawing attention after recent share price moves, with a return of 23.5% over the past month and 16.7% over the past 3 months. See our latest analysis for Synopsys. At around $489 per share, the stock has recently seen a 23.5% 1 month share price return and a 16.7% 3 month share price return. The 1 year total shareholder return of 2.43% and 5 year total shareholder return of 110.43% frame this latest move within a...
Based on the average brokerage recommendation (ABR), Synopsys (SNPS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PRGS vs. SNPS: Which Stock Is the Better Value Option?
Synopsys (SNPS) concluded the recent trading session at $483.89, signifying a -2.94% move from its prior day's close.
In April 2026, Synopsys announced an expanded collaboration with Atomera to enhance gallium nitride device modeling for radio frequency and power semiconductor applications, building on their long-standing work integrating Atomera’s MST technology into the Sentaurus TCAD environment. This extension into GaN workflows, supported by Atomera’s MSTcad toolset, could make it easier for chipmakers to assess MST’s impact in high-value RF and power markets. We’ll now examine how this expanded...
Synopsys will release its second-quarter earnings soon, and analysts anticipate a double-digit profit dip.
Synopsys (SNPS) closed at $456.85 in the latest trading session, marking a -4.28% move from the prior day.